| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |